Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 5 October 2007: Vol. 318. no. 5847, pp. 28 - 29 DOI: 10.1126/science.318.5847.28
|
|
News of the Week
AIDS RESEARCH: Promising AIDS Vaccine's Failure Leaves Field Reeling
Jon Cohen
The failure of a promising AIDS vaccine in a large human trial, dubbed STEP, has stunned researchers and raised concerns about the broader T-cell vaccine concept and the future of AIDS vaccine research and development.
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens.
- P. Mooij, S. S. Balla-Jhagjhoorsingh, N. Beenhakker, P. van Haaften, I. Baak, I. G. Nieuwenhuis, S. Heidari, H. Wolf, M.-J. Frachette, K. Bieler, et al. (2009)
J. Virol.
83, 5881-5889
| Abstract »
| Full Text »
| PDF »
- Screening for NNRTIs with Slow Dissociation and High Affinity for a Panel of HIV-1 RT Variants.
- M. Elinder, H. Nordstrom, M. Geitmann, M. Hamalainen, L. Vrang, B. Oberg, and U. H. Danielson (2009)
J Biomol Screen
14, 395-403
| Abstract »
| PDF »
- Constitutive Activation of the PrfA Regulon Enhances the Potency of Vaccines Based on Live-Attenuated and Killed but Metabolically Active Listeria monocytogenes Strains.
- P. Lauer, B. Hanson, E. E. Lemmens, W. Liu, W. S. Luckett, M. L. Leong, H. E. Allen, J. Skoble, K. S. Bahjat, N. E. Freitag, et al. (2008)
Infect. Immun.
76, 3742-3753
| Abstract »
| Full Text »
| PDF »
- Multifunctional T-Cell Characteristics Induced by a Polyvalent DNA Prime/Protein Boost Human Immunodeficiency Virus Type 1 Vaccine Regimen Given to Healthy Adults Are Dependent on the Route and Dose of Administration.
- A. Bansal, B. Jackson, K. West, S. Wang, S. Lu, J. S. Kennedy, and P. A. Goepfert (2008)
J. Virol.
82, 6458-6469
| Abstract »
| Full Text »
| PDF »
- A DNA Vaccine Prime Followed by a Liposome-Encapsulated Protein Boost Confers Enhanced Mucosal Immune Responses and Protection.
- K. Yang, B. J. Whalen, R. S. Tirabassi, L. K. Selin, T. S. Levchenko, V. P. Torchilin, E. H. Kislauskis, and D. L. Guberski (2008)
J. Immunol.
180, 6159-6167
| Abstract »
| Full Text »
| PDF »
- The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?.
- R.-P. Sekaly (2008)
J. Exp. Med.
205, 7-12
| Abstract »
| Full Text »
| PDF »
|
|